Reuters logo
BRIEF-Galmed Pharmaceuticals Q4 loss per share $0.40
March 23, 2017 / 11:54 AM / 6 months ago

BRIEF-Galmed Pharmaceuticals Q4 loss per share $0.40

March 23 (Reuters) - Galmed Pharmaceuticals Ltd:

* Galmed Pharmaceuticals reports fourth quarter and full year 2016 financial results

* Q4 loss per share $0.40

* Q4 earnings per share view $-0.30 -- Thomson Reuters I/B/E/S

* Galmed Pharmaceuticals Ltd- cash and cash equivalents and marketable securities about $15.5 million as of Dec 31, 2016, versus about $23.0 million as of December 31, 2015 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below